EMERYVILLE, Calif., Oct. 26,
2023 /PRNewswire/ -- Dynavax Technologies
Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical
company developing and commercializing innovative vaccines, will
report third quarter 2023 financial results on Thursday, November 2, 2023, after the U.S.
financial markets close.
Dynavax will host a conference call and live audio webcast on
Thursday, November 2, 2023, at
4:30 p.m. ET/1:30 p.m. PT.
The live audio webcast may be accessed through the "Events &
Presentations" page on the "Investors" section of the Company's
website at https://investors.dynavax.com/events-presentations. A
replay of the webcast will be available for 30 days following the
live event.
To dial into the call, participants will need to register for
the call using the caller registration link. It is recommended that
participants dial into the conference call or log into the webcast
approximately 10 minutes prior to the call.
About Dynavax
Dynavax is a commercial-stage
biopharmaceutical company developing and commercializing innovative
vaccines to help protect the world against infectious diseases. The
Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis
B Vaccine (Recombinant), Adjuvanted], which is approved in the
U.S., the European Union and Great
Britain for the prevention of infection caused by all known
subtypes of hepatitis B virus in adults 18 years of age and older,
and CpG 1018® adjuvant, currently used in multiple adjuvanted
COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a
premier vaccine adjuvant with adjuvanted vaccine clinical programs
for shingles and Tdap, and through global collaborations, currently
focused on adjuvanted vaccines for COVID-19, plague, seasonal
influenza and universal influenza. For more information about our
marketed products and development pipeline, visit
www.dynavax.com and follow Dynavax on LinkedIn and
Twitter.
For Investors/Media:
Paul
Cox
pcox@dynavax.com
510-665-0499
Nicole Arndt
narndt@dynavax.com
510-665-7264
View original content to download
multimedia:https://www.prnewswire.com/news-releases/dynavax-to-report-third-quarter-2023-financial-results-and-host-conference-call-on-november-2-2023-301968996.html
SOURCE Dynavax Technologies